Adult Diphtheria Vaccination
Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998;4(4):53950.
Bureau of Communication and Public Service, Ministry of Health, Republic of Indonesia. Pemerintah Optimis KLB Difteri Bisa Teratasi. Downloaded from: http://www.depkes.go.id/article/view/18011500004/pemerintah-optimis-klb-difteri-bisa-teratasi.html. Last access: April 30, 2018.
Bureau of Communication and Public Service, Ministry of Health, Republic of Indonesia. Ingat, ORI Difteri Ada 3 Putaran. Downloaded from: http://www.depkes.go.id/article/view/18010800001/ingat-ori-difteri-ada-3-putaran.html. Last access: April 30, 2018.
Tiwari TSP, Golaz A, Yu DT, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis. 2008;46:395401.
World Health Organization. Diphtheria vaccine. Wkly Epidemiol Rec. 2006:81:2432.
Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients. J Immunol. 1946;54:32547.
McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136:6606.
Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):144.
Jadhav S, Gautam M, Gairola S. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices. Clin Microbiol Infect. 2014;20 (Suppl.5): 3744.
Centers for Disease Control (CDC). General recommendation on immunization recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Recomm Rep. 2011;60(No. RR-2):164.
Halperin SA, Scheifele D, De Serres G, et al. Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose. Vaccine. 2012;30(5):97482.
Thierry-Carstensen B, Jordan K, Uhlving HH, et al. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012;30(37):546471.
Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-4):151.
Khodr ZG, Bukowinski AT, Gmbs GR, Conlin AMS. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections. Vaccine. 2017;35(42):560310.
Mertens PL, Stals FS, Schellekens JF, Houben AW, Huisman J. An epidemic of pertussis among elderly people in a religious institution in the Netherlands. Eur J Clin Microbiol Infect Dis. 1999;18:2427.
Moro PL, Yue X, Lewis P, Haber P, Broder K. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VARS), 2005-2010. Vaccine. 2011;29:94048.
Tseng HF, Sy LS, Qian L, et al. Vaccine Safety Datalink (VSD) Team. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013;56:31521.
Weston WM, Friedland LR, Wu X, Howe B. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix()): results of two randomized trials. Vaccine. 2012;30(9):17218.
- There are currently no refbacks.